Bioequivalent Letermovir Usage for Prophylaxis in Haploidentical Stem Cell Transplantation at High Risk of CMV Reactivation: A Report of Two Cases From India.

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/40432636

Arijit Nag; Asish Rath; Baalamurugan Kt; Debranjani Chattopadhyay; Dibakar Podder; Jeevan Kumar; Reena Nair; Rizwan Javed; Saswata Saha; Shouriyo Ghosh; Soumyadip Chatterji; Suyash Bharat

May 28, 2025